Trump's Pfizer Deal Aims to Slash US Drug Prices
Former President Donald Trump announces groundbreaking agreement with Pfizer to slash prescription drug costs, vowing to overhaul US healthcare system if re-elected.
Category : Search result: pharmaceutical lobbying
Big Pharma's Legal War Threatens NHS Drug Access
Pharmaceutical giants are launching an unprecedented legal assault against the UK government, threatening NHS access to vital medicines and putting patient care at risk in a battle over drug pricing.
Pfizer sued Medicaid for $105M during COVID vaccine rollout
Pharmaceutical giant Pfizer pursued a staggering $105 million Medicaid reimbursement lawsuit against the Trump administration while seeking regulatory approval for its COVID-19 vaccine, reveals explosive court documents.
Weight-Loss Jabs: The Profit-Driven Health Crisis
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
GSK's Growth Gamble: Walmsley's Steady Hand Faces Test
Five years into her tenure, CEO Emma Walmsley has stabilised GSK's ship, but looming patent cliffs and vaccine market pressures cast shadows over ambitious growth targets.
Six-month HIV prevention jab for 120 countries by 2027
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
UK Worst in Europe for Drug Prices, Says Eli Lilly
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Gold Prices Surge as Pharma Stocks Face Pressure
Financial markets experienced significant volatility as gold hit record highs while pharmaceutical giant Eli Lilly faced pressure over drug pricing concerns. Get the latest analysis on today's market movements.
Trump's Tylenol Gaffe Sends Wall Street into Frenzy
Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.
Tylenol makers hit back at Trump's vaccine comparison
Pharmaceutical giant Kenvue has issued a stern rebuke to Donald Trump after he suggested the COVID-19 vaccine was comparable to the Tylenol murders, calling the analogy 'irresponsible'.
Chinese Executive Jailed in US Fentanyl Case
A senior Chinese pharmaceutical executive has been sentenced to 15 years in a US prison for conspiring to manufacture and distribute fentanyl, marking a significant victory in the transatlantic fight against the opioid crisis.
NHS Drug Pricing: The Art of the Deal Saving Millions
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
NHS Must Reverse Medicines Investment Decline - Minister
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Trump Threatens NHS Drug Pricing: UK Faces US Medicine Costs
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
AstraZeneca Pauses £500m Cambridge HQ Investment
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
Common Meds Linked to Youth Suicide Surge, Study Finds
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Trump pressured FDA to fast-track Covid vaccine before election
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Mounjaro KwikPens launch without price reduction
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Congress Grills Pharma Over Child Vaccine-Linked Illnesses
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Boris Johnson traded PM contacts for global business deals
Exclusive investigation reveals Boris Johnson leveraged his Prime Ministerial contacts for multi-million pound business ventures with foreign governments and oligarchs just months after leaving Downing Street.
Johnson & Cummings' Secret Palantir Meeting Revealed
Explosive new allegations reveal a clandestine meeting between Boris Johnson and Dominic Cummings, brokered by tech billionaire Peter Thiel, to discuss a lucrative government contract for data firm Palantir just weeks after the 2019 election.
Johnson's £700k Maduro meeting invoice revealed
Exclusive: A leaked invoice shows Boris Johnson's company charged a US lobbyist over £700,000 for a clandestine meeting with Venezuela's controversial president Nicolás Maduro, raising serious ethical and legal questions.
Page 1 of 4